The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma
Version of Record online: 26 APR 2013
Copyright © 2013 American Cancer Society
Volume 119, Issue 12, pages 2350–2357, 15 June 2013
How to Cite
Hall, W. A., Colbert, L. E., Liu, Y., Gillespie, T., Lipscomb, J., Hardy, C., Kooby, D. A., Prabhu, R. S., Kauh, J. and Landry, J. C. (2013), The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma. Cancer, 119: 2350–2357. doi: 10.1002/cncr.28047
- Issue online: 4 JUN 2013
- Version of Record online: 26 APR 2013
- Manuscript Accepted: 22 JAN 2013
- Manuscript Revised: 18 DEC 2012
- Manuscript Received: 6 NOV 2012
- 10[no authors listed] Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group. Cancer. 1987;59:2006–2010.
- 13Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol. 2008;26:3503–3510., , , et al.
- 15Radiation therapy is associated with improved survival in patients with pancreatic adenocarcinoma: results of a study from the Surveillance, Epidemiology, and End Results (SEER) registry data. Cancer. 2007;110:2191–2201., , , .
- 25Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704–a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 2012;82:809–816., , , et al.